| (CNY) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 2.45B | 4.07% |
| Operating expense | — | — |
| Net income | 10.23M | -120.83% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 603520.SS returned -23.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -5.2% |
| 1 year | -23.3% |
| 5 years | -65.3% |
| 10 years | -44.5% |
| All-time high | ¥67.52 (Aug 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 603520.SS would be worth today ›Yes. Zhejiang Starry Pharmaceutical Co.,Ltd. paid 2 dividends over the past 12 months. The most recent was ¥0.25 per share on Jun 4, 2026. The dividend yield is 3.45%.
Zhejiang Starry Pharmaceutical Co.,Ltd. is part of the Healthcare sector.
Zhejiang Starry Pharmaceutical Co.,Ltd. has a market cap of 3.91B CNY, based on the latest quote.
